EP-11 Systemic Disease and Endodontics
CE Hours: 1.0
Description: Understanding of the relationship between Endodontics and systemic disease has evolved considerably over the past century, from the initial pseudo-science related to the focal infection theory to modern day understanding of the pathogenesis inflammatory diseases and their interrelationship. This session will discuss recent information on the association of endodontic disease pathogenesis as well as treatment outcomes with major chronic systemic diseases and their treatment.
Learning Objectives:
- Identify the relationship between systemic diseases and the pathogenesis of endodontic diseases
- Discuss the relationship between systemic diseases and the treatment outcomes of endodontic diseases
- Present clinically relevant and evidence-based discussion points about this subject
Key:
Complete
Next
Failed
Available
Locked
Ashraf F. Fouad, D.D.S., M.S.
Dr. Fouad obtained his DDS, Certificate of Endodontics and MS at the University of Iowa.
He served on the faculty and in various administrative roles at University of Connecticut Health Center, the University of Maryland, and the University of North Carolina at Chapel Hill. He is currently Professor and Chair, Department of Endodontics, and Director, Advanced Endodontics Program, at the University of Alabama at Birmingham.
Dr. Fouad has published over 100 peer-reviewed manuscripts, 24 textbook chapters, and 140 abstracts. He edited and co-authored the textbooks: Endodontic Microbiology, as well as the fifth and sixth editions of Endodontics: Principles and Practice. He is a Diplomate and Past President of the American Board of Endodontics, and an Associate Editor of the Journal of Endodontics and Dental Traumatology. He received the Distinguished Scientist Award from the Pulp Biology and Regeneration Group of the International Association of Dental Research.
Speaker Disclosure
I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation